Difference between revisions of "Hepatorenal syndrome"

(Created page with "==Pathophysiology== Functional renal vasoconstriction leading to severe redxn in GFR with minimal renal histologic abnormalities ==Diagnosis== Type 1: doubling of serum C...")
 
Line 1: Line 1:
 
==Pathophysiology==
 
==Pathophysiology==
 
 
 
Functional renal vasoconstriction leading to severe redxn in GFR with minimal renal histologic abnormalities
 
Functional renal vasoconstriction leading to severe redxn in GFR with minimal renal histologic abnormalities
 
 
  
 
==Diagnosis==
 
==Diagnosis==
 
+
#Type 1: doubling of serum Cr to > 2.5mg/dl in < 2wk
 
+
#Type 2: stable or less rapidly progressive course than Type 1
Type 1: doubling of serum Cr to > 2.5mg/dl in < 2wk
+
#Type 1 & 2 both require^:
 
+
##Cr >1.5mg/dl
Type 2: stable or less rapidly progressive course than Type 1
+
##Cr NOT reduced below 1.5mg/dl with administration of albumin (1g/kg) and after a minimum of 2 days off diuretics  
 
+
##Abscence of current or recent rx with potentially nephrotoxic drugs
Type 1 & 2 both require*:
+
##Abscence of shock
 
+
##Abscence of renal parenchymal disease (urinary excretion of >500mg protein/d, >50 RBC/hpf, abnl kidneys on U/S)
-Cr >1.5mg/dl
 
 
 
-Cr NOT reduced below 1.5mg/dl with administration of albumin (1g/kg) and after a minimum of 2 days off diuretics  
 
 
 
-Abscence of current or recent rx with potentially nephrotoxic drugs
 
 
 
-Abscence of shock
 
 
 
-Abscence of renal parenchymal disease (urinary excretion of >500mg protein/d, >50 RBC/hpf, abnl kidneys on U/S)
 
 
 
 
 
 
 
  
 
==DDx==
 
==DDx==
 
+
#Hypovolemia-induced renal failure (GI bleed or fluid losses 2/2 diuretics, diarrhea most common)
 
+
#Parenchymal renal disease (proteinuria >500mg protein/d, >50 RBC/hpf or both; confirmed with renal biopsy)
-Hypovolemia-induced renal failure (GI bleed or fluid losses 2/2 diuretics, diarrhea most common)
+
#Drug-induced renal failure (current NSAIDs, aminoglycosides)
 
 
-Parenchymal renal disease (proteinuria >500mg protein/d, >50 RBC/hpf or both; confirmed with renal biopsy)
 
 
 
-Drug-induced renal failure (current NSAIDs, aminoglycosides)
 
 
 
 
  
 
==Treatment==
 
==Treatment==
 
+
#Vasoconstrictors
 
+
##Terlipressin: 0.5-1mg q 4-6 IV us 5-15d
Vasoconstrictors
+
##Norepi: 0.5-3mg/hr to increase MAP by 10mmHg
 
+
##Midrodrine: 7.5mg PO tid with Octreotide 100mcg sq
    -Terlipressin: 0.5-1mg q 4-6 IV us 5-15d
+
#Albumin: 1-1.5g/kg with one of above
 
+
#Other: TIPS, renal replacement therapy
    -Norepi: 0.5-3mg/hr to increase MAP by 10mmHg
 
 
 
    -Midrodrine: 7.5mg PO tid with Octreotide 100mcg sq
 
 
 
Albumin: 1-1.5g/kg with one of above
 
 
 
Other: TIPS, renal replacement therapy
 
 
 
 
  
 
==Disposition==
 
==Disposition==
 
+
#1-month survival: 50%
 
+
#6-month survival: 20%
1-month survival: 50%
 
 
 
6-month survival: 20%
 
 
 
 
  
 
==Source==
 
==Source==
 
 
 
Adapted from NEJM vol 361 no 13 P. Gines
 
Adapted from NEJM vol 361 no 13 P. Gines
  
*International Ascites Club criteria
+
^International Ascites Club criteria
 
 
 
 
 
 
  
 
[[Category:GI]]
 
[[Category:GI]]

Revision as of 11:59, 14 March 2011

Pathophysiology

Functional renal vasoconstriction leading to severe redxn in GFR with minimal renal histologic abnormalities

Diagnosis

  1. Type 1: doubling of serum Cr to > 2.5mg/dl in < 2wk
  2. Type 2: stable or less rapidly progressive course than Type 1
  3. Type 1 & 2 both require^:
    1. Cr >1.5mg/dl
    2. Cr NOT reduced below 1.5mg/dl with administration of albumin (1g/kg) and after a minimum of 2 days off diuretics
    3. Abscence of current or recent rx with potentially nephrotoxic drugs
    4. Abscence of shock
    5. Abscence of renal parenchymal disease (urinary excretion of >500mg protein/d, >50 RBC/hpf, abnl kidneys on U/S)

DDx

  1. Hypovolemia-induced renal failure (GI bleed or fluid losses 2/2 diuretics, diarrhea most common)
  2. Parenchymal renal disease (proteinuria >500mg protein/d, >50 RBC/hpf or both; confirmed with renal biopsy)
  3. Drug-induced renal failure (current NSAIDs, aminoglycosides)

Treatment

  1. Vasoconstrictors
    1. Terlipressin: 0.5-1mg q 4-6 IV us 5-15d
    2. Norepi: 0.5-3mg/hr to increase MAP by 10mmHg
    3. Midrodrine: 7.5mg PO tid with Octreotide 100mcg sq
  2. Albumin: 1-1.5g/kg with one of above
  3. Other: TIPS, renal replacement therapy

Disposition

  1. 1-month survival: 50%
  2. 6-month survival: 20%

Source

Adapted from NEJM vol 361 no 13 P. Gines

^International Ascites Club criteria